<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05626010</url>
  </required_header>
  <id_info>
    <org_study_id>AAP-ibuprofen-thyroid</org_study_id>
    <nct_id>NCT05626010</nct_id>
  </id_info>
  <brief_title>Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy</brief_title>
  <official_title>Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acetaminophen and ibuprofen has been safely used for a long time and reduces postoperative&#xD;
      pain and opioid dosages. Investigators are planning to compare the efficacy of 1)&#xD;
      acetaminophen only and 2) acetaminophen and ibuprofen combination at postoperative pain after&#xD;
      thyroidectomy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acetaminophen and ibuprofen has been safely used for a long time and reduces postoperative&#xD;
      pain and opioid dosages. Investigators are planning to compare the efficacy of 1)&#xD;
      acetaminophen 1g only and 2) the combination of acetaminophen 1g and ibuprofen 300mg at&#xD;
      postoperative pain after thyroidectomy. Some recovery valuables such as the postoperative&#xD;
      pain and opioid requirements will be assessed&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 23, 2022</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>during 30 minutes after surgery</time_frame>
    <description>the maximal postoperative pain severity using pain scale(visual analogue scale; 0 cm=no pain; 10 cm=the worst pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain killer requirement</measure>
    <time_frame>during 30 minutes after surgery</time_frame>
    <description>the incidence of the patients who require pain killer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Thyroid Disease</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>acetaminophen 1g iv dripping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the combination of acetaminophen 1g and ibuprofen 300mg iv dripping</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>acetaminophen 1g iv dripping at end of surgery</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>ibuprofen 300mg iv dripping at end of surgery</description>
    <arm_group_label>experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  the patients undergoing scheduled thyroidectomy&#xD;
&#xD;
          -  American Society of Anesthesiologists status 1 or 2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  refusal to be enrolled in the study&#xD;
&#xD;
          -  emergency surgery&#xD;
&#xD;
          -  hepatic or renal disease&#xD;
&#xD;
          -  on chronic pain medications&#xD;
&#xD;
          -  psychiatric disorders&#xD;
&#xD;
          -  pregnancy, lactation&#xD;
&#xD;
          -  allergy or contraindication to the study drug&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>youngeun moon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul St. Mary's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>youngeun moon, MD, PhD</last_name>
    <phone>822-2258-6163</phone>
    <email>0910momo@naver.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>jaesik park, MD</last_name>
    <phone>822-2258-6163</phone>
    <email>cmcanepm@catholic.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <state>Seocho-gu</state>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youngeun Moon, MD, PhD</last_name>
      <phone>01090801020</phone>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 15, 2022</study_first_submitted>
  <study_first_submitted_qc>November 15, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2022</study_first_posted>
  <last_update_submitted>November 23, 2022</last_update_submitted>
  <last_update_submitted_qc>November 23, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Young Eun Moon</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

